Basic Information
ID: ALA4270323
Type: Functional
Description: Antagonist activity at human SSR5 expressed in CHOK1 cells assessed as inhibition of forskolin-induced cAMP accumulation at 8.3 mM preincubated for 15 mins followed by forskolin addition measured after 1 hr by LANCE assay relative to control
Organism: Homo sapiens
Activity Charts
Bioactivity
Activity Types for Assay ALA4270323
Imax
Compound Summary
| Parent Molecular Weight | ALogP | Polar Surface Area |
|---|---|---|
| 548.61 | 5.98 | 5.98 |
| 450.54 | 4.44 | 4.44 |
| 525.53 | 5.77 | 5.77 |
| 437.50 | 3.66 | 3.66 |
| 474.48 | 5.27 | 5.27 |
| 485.63 | 5.82 | 5.82 |
| 514.50 | 4.80 | 4.80 |
| 466.60 | 5.15 | 5.15 |
| 576.54 | 6.82 | 6.82 |
| 474.48 | 5.27 | 5.27 |
| 542.61 | 6.11 | 6.11 |
| 459.59 | 5.25 | 5.25 |
| 448.56 | 4.46 | 4.46 |
| 483.01 | 5.12 | 5.12 |
| 578.51 | 6.79 | 6.79 |
| 508.92 | 5.93 | 5.93 |
| 487.60 | 5.79 | 5.79 |
| 519.30 | 5.58 | 5.58 |
| 553.01 | 6.85 | 6.85 |
| 506.95 | 5.95 | 5.95 |
| 593.43 | 7.68 | 7.68 |
| 546.64 | 6.01 | 6.01 |
| 474.48 | 5.27 | 5.27 |
| 542.61 | 6.11 | 6.11 |
| 498.60 | 3.83 | 3.83 |
| 593.43 | 7.28 | 7.28 |
| 450.54 | 4.48 | 4.48 |
| 577.60 | 7.00 | 7.00 |
| 486.59 | 5.83 | 5.83 |